Yecuris Corporation
Biotechnology ResearchOregon, United States11-50 Employees
Yecuris Corporation develops data from human hepatocytes to support liver research. Its FRG platform uses chimeric animals with more than 70 percent of the liver replaced by human hepatocytes, enabling liver insights at cellular, tissue, and whole-animal levels. Researchers working on gene therapies, NASH, liver disease, or metabolism and toxicology testing rely on these models to obtain liver-specific data early in their development. The company is based in Portland, Oregon, and operates as a small to mid-sized biotechnology firm. Having operated for more than ten years, Yecuris is positioned as a provider of human liver data within the biotechnology research ecosystem.